267 related articles for article (PubMed ID: 22888600)
1. In vitro potency tests: challenges encountered during method development.
Yomayuza CL; Thiel HJ; König M
Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
[TBL] [Abstract][Full Text] [Related]
2. Potency testing of inactivated rabies vaccines using a serological method.
Kamphuis E; Krämer B; Schildger H; Duchow K
Dev Biol (Basel); 2012; 134():23-7. PubMed ID: 22888591
[TBL] [Abstract][Full Text] [Related]
3. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
[TBL] [Abstract][Full Text] [Related]
4. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
[TBL] [Abstract][Full Text] [Related]
5. The rabies peripheral challenge test: more accurate determination of vaccine potency.
Wunderli PS; Dreesen DW; Miller TJ; Baer GM
Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
[TBL] [Abstract][Full Text] [Related]
7. G-protein based ELISA as a potency test for rabies vaccines.
Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
[TBL] [Abstract][Full Text] [Related]
8. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A
Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458
[No Abstract] [Full Text] [Related]
9. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
10. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
11. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model.
Bruckner L; Kihm U
Dev Biol Stand; 1986; 64():93-7. PubMed ID: 3792660
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies.
Wu X; Franka R; Henderson H; Rupprecht CE
Vaccine; 2011 Jun; 29(25):4195-201. PubMed ID: 21514343
[TBL] [Abstract][Full Text] [Related]
13. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
[TBL] [Abstract][Full Text] [Related]
14. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
15. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
Ferguson M; Seagroatt V; Schild GC
Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to nucleic acid vaccines to rabies virus.
Xiang ZQ; Spitalnik SL; Cheng J; Erikson J; Wojczyk B; Ertl HC
Virology; 1995 Jun; 209(2):569-79. PubMed ID: 7778289
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a non-invasive, inhalational challenge method for rabies vaccine potency assay.
Lewis CE; Reising MM; Fry AM; Conrad SK; Siev D; Gatewood DM; Hermann JR
J Virol Methods; 2013 Jun; 190(1-2):49-52. PubMed ID: 23557669
[TBL] [Abstract][Full Text] [Related]
18. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein.
Loza-Rubio E; Rojas-Anaya E; López J; Olivera-Flores MT; Gómez-Lim M; Tapia-Pérez G
Vaccine; 2012 Aug; 30(37):5551-6. PubMed ID: 22749836
[TBL] [Abstract][Full Text] [Related]
19. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
Perrin P; Jacob Y; Desmézières E; Tordo N
Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
[TBL] [Abstract][Full Text] [Related]
20. Antigen content versus volume of rabies vaccines administered intradermally.
Dodet B
Biologicals; 2011 Nov; 39(6):444-5. PubMed ID: 22000166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
